GW501516 / Cardarine

GW501516 / Cardarine is a experimental PPAR-delta agonist intended for controlled laboratory work. It is studied in experimental systems involving PPAR-delta, lipid oxidation, skeletal-muscle, and metabolic models. Descriptions of research pathways do not establish safety, effectiveness, or suitability for human or veterinary use.

Research areas include:
• PPAR-delta transcriptional activation
• Fatty-acid oxidation and lipid metabolism
• Skeletal-muscle oxidative pathways
• Carcinogenicity and long-term safety-signal research

Research limitations and safety:
• Published evidence and human safety data may be limited; composition, identity, purity, and experimental controls should be independently verified. Published or regulatory sources identify material safety uncertainties or adverse signals requiring particular caution.
• No dosing, administration, or therapeutic-use guidance is provided.

being sold for research only.